Veterinary Infectious Disease Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Technology (Immunodiagnostics, Molecular Diagnostics, Other Veterinary Diagnostic Technologies), By Animal Type (Companion Animals, Food Producing Animals), By End User (Reference Laboratories, Veterinary Laboratories and Clinics, Point of Care / In House Testing, Research Institutes and Universities), By Region and Competition
Global Veterinary Infectious Disease Diagnostics Market has valued at USD 1.52 Billion in 2022 and is anticipated to project steady growth in the forecast period with a CAGR of 5.25% through 2028. The global veterinary industry is experiencing a paradigm shift, with increased focus on preventive healthcare and diagnostics for animals. As concerns about zoonotic diseases and the economic impact of infectious outbreaks on livestock rise, the demand for advanced veterinary infectious disease diagnostics is growing. The Global Veterinary Infectious Disease Diagnostics Market is at the forefront of this evolution, playing a crucial role in safeguarding animal health, ensuring food safety, and preventing the transmission of diseases between animals and humans.
The increasing incidence of zoonotic diseases has raised awareness about the interconnectedness of animal and human health. Diseases such as avian influenza, brucellosis, and leptospirosis can be transmitted between animals and humans, emphasizing the need for robust diagnostic tools. Advances in diagnostic technologies, such as PCR (Polymerase Chain Reaction) and next-generation sequencing, have revolutionized the accuracy and speed of veterinary infectious disease diagnostics. These technologies allow for early detection and precise identification of pathogens. The growing trend of pet ownership has led to an increased demand for veterinary services, including diagnostics. Pet owners are increasingly investing in preventive healthcare for their animals, driving the demand for sophisticated diagnostic tests. With the globalization of the livestock industry, the risk of disease transmission across borders has escalated. This has prompted regulatory bodies and stakeholders to implement stringent diagnostic protocols to ensure the health and safety of animals and consumers.
Key Market Drivers
Increasing Pet Ownership and Humanization of Pets is Driving the Global Veterinary Infectious Disease Diagnostics Market.
In recent years, there has been a notable global shift in the way people perceive and care for their pets. The increasing trend of pet ownership and the growing humanization of pets have not only led to an upsurge in spending on pet healthcare but have also been significant drivers of the veterinary infectious disease diagnostics market. This market, which plays a crucial role in ensuring the health and well-being of animals, has witnessed unprecedented growth as pet owners seek advanced diagnostic solutions for their beloved companions. The worldwide surge in pet ownership is a multifaceted phenomenon, influenced by factors such as urbanization, changing lifestyles, and an increased understanding of the emotional and physical benefits that pets bring to their owners. As more people open their homes to pets, whether they be dogs, cats, birds, or exotic animals, the demand for comprehensive veterinary care has risen significantly.
This burgeoning population of pets has given rise to a corresponding demand for advanced diagnostic tools to detect and manage infectious diseases. Veterinary infectious disease diagnostics encompass a range of tests and procedures that aid in the identification and monitoring of diseases in animals. These diagnostics not only help in the early detection of illnesses but also play a crucial role in preventing the spread of infectious diseases among animals and, in some cases, to humans.
The increasing humanization of pets is another major trend shaping the veterinary infectious disease diagnostics market. Pet owners are now more inclined to view their animals as integral members of the family, leading to a greater willingness to invest in their health and well-being. This paradigm shift has translated into higher expectations for the quality of veterinary care, including advanced diagnostics, and has fueled the growth of the global market. Pet owners are seeking not just basic veterinary services but also cutting-edge diagnostics that can provide more accurate and timely results. This shift in consumer behaviour has prompted veterinary diagnostic companies to innovate and develop new technologies and testing methods to meet the evolving demands of pet owners.
Rising Incidence of Zoonotic Diseases is Driving the Global Veterinary Infectious Disease Diagnostics Market
Zoonotic diseases, which are infections that can be transmitted between animals and humans, have garnered increased attention in recent years due to their potential for rapid spread and devastating impact on both animal and human populations. The rise in these diseases has led to a growing demand for effective diagnostic tools, driving the expansion of the global veterinary infectious disease diagnostics market. Zoonotic diseases represent a significant public health concern, as evidenced by outbreaks such as the H1N1 influenza pandemic and the more recent COVID-19 pandemic. These diseases can originate in animals and jump to humans through various means, including direct contact, consumption of contaminated food or water, and exposure to vectors like mosquitoes and ticks.
The interconnectedness of animal and human health is increasingly recognized as a crucial aspect of global health. As human populations expand and encroach on natural habitats, the risk of zoonotic disease transmission escalates. Climate change, international travel, and the global movement of goods further contribute to the complexity of disease transmission dynamics. Efficient and accurate diagnostics play a pivotal role in preventing, controlling, and managing zoonotic diseases. In response to the rising threat, the global veterinary infectious disease diagnostics market has witnessed substantial growth. Diagnostic techniques include traditional methods such as serological testing and microbial culture, as well as advanced molecular techniques like polymerase chain reaction (PCR) and next-generation sequencing.
Key Market Challenges
High Cost of Diagnostic Equipment
The field of veterinary diagnostics plays a crucial role in safeguarding the health of animals and preventing the spread of infectious diseases. As technology continues to advance, the demand for accurate and timely diagnostics in the veterinary sector has grown exponentially. However, one formidable challenge hindering the progress of the Global Veterinary Infectious Disease Diagnostics Market is the exorbitant cost associated with diagnostic equipment. The high cost of diagnostic equipment limits access to advanced veterinary diagnostics, especially in developing regions. Rural areas, where agriculture is a significant part of the economy, often lack access to state-of-the-art diagnostic tools. This limited accessibility can impede early detection and timely intervention, allowing infectious diseases to spread unchecked.
Veterinary clinics and laboratories, facing the burden of expensive diagnostic equipment, may struggle to invest in the latest technologies. The financial strain on these establishments not only affects their ability to provide cutting-edge services but also impacts their competitiveness in the market. High equipment costs can also hinder research and development efforts in veterinary diagnostics. Smaller companies and research institutions may find it challenging to invest in innovative technologies, slowing down progress in the field and limiting the development of new diagnostic methods. The cost of diagnostic services is inevitably passed on to pet owners and livestock farmers. This can deter individuals from seeking early diagnostic testing for their animals, leading to delayed disease detection and increased treatment costs in the long run.
Key Market Trends
Technological Advancements
In recent years, the global veterinary industry has experienced a significant transformation, with a sharp focus on technological advancements to address the challenges posed by infectious diseases in animals. The Veterinary Infectious Disease Diagnostics Market has witnessed a remarkable surge, driven by cutting-edge technologies that are revolutionizing the way diseases are diagnosed and treated in animals. One of the primary drivers of the veterinary infectious disease diagnostics market is the continuous evolution of diagnostic technologies. Traditional methods are being replaced or complemented by more sophisticated and rapid techniques. Molecular diagnostics, next-generation sequencing, and advanced imaging technologies have become instrumental in providing quick and accurate diagnoses. These technologies not only enhance the speed of diagnosis but also improve the precision and reliability of results.
Segmental Insights
Technology Insights
Based on the category of technology, Immunodiagnostics emerged as the dominant player in the global market for Veterinary Infectious Disease Diagnostics in 2022. Immunodiagnostics relies on the highly specific interactions between antibodies and antigens. This specificity allows for accurate detection of pathogens, minimizing the chances of false-positive or false-negative results. High sensitivity ensures that even low levels of infection can be identified, enabling early intervention and treatment. One of the significant advantages of immunodiagnostics is its ability to deliver rapid results. Quick and accurate diagnosis is crucial in preventing the spread of infectious diseases within animal populations and reducing the economic impact on the agricultural and veterinary sectors.
Animal Type Insights
The Companion Animals segment is projected to experience rapid growth during the forecast period. Companion animals, which include pets like dogs, cats, and horses, have become integral members of households worldwide. The deep emotional bonds shared between humans and their furry friends have elevated the status of these animals from mere pets to cherished family members. As the number of companion animals continues to rise globally, so does the concern for their health and well-being. The Companion Animals segment's dominance in the veterinary infectious disease diagnostics market can be attributed to several key factors. The increasing pet ownership rates, rising awareness about animal health, and a growing trend of preventive healthcare for pets are some of the primary drivers. Moreover, the evolving regulatory landscape and a surge in research and development activities in the veterinary diagnostics sector have further propelled market growth. The demand for accurate and efficient diagnostic tools for companion animals has prompted companies to invest in innovative solutions, fostering a competitive yet dynamic market.
Regional Insights
North America emerged as the dominant player in the global Veterinary Infectious Disease Diagnostics market in 2022, holding the largest market share in terms of value. North America, particularly the United States and Canada, has been at the forefront of technological innovation in the healthcare and diagnostics industries. The region's commitment to research and development has resulted in cutting-edge diagnostic tools and techniques, enabling more accurate and timely identification of infectious diseases in animals. The rising trend of pet ownership in North America has led to a surge in demand for advanced veterinary diagnostics. Pet owners are increasingly investing in the health and well-being of their animals, driving the need for sophisticated diagnostic tools to identify and manage infectious diseases effectively.
Key Market Players
BIOMЙRIEUX
Heska Corporation
Neogen Corporation
INDICAL BIOSCIENCE GmbH
Randox Laboratories Ltd.
Thermo Fisher Scientific Inc.
Creative Diagnostics
DRG INSTRUMENTS GMBH
Chembio Diagnostic Systems, Inc.
Eurofins Technologies
Agrolabo S.p.A.
Abbott Laboratories inc.
Danaher Corporation
Report Scope:
In this report, the Global Veterinary Infectious Disease Diagnostics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Veterinary Infectious Disease Diagnostics Market.
Available Customizations:
Global Veterinary Infectious Disease Diagnostics market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
The increasing incidence of zoonotic diseases has raised awareness about the interconnectedness of animal and human health. Diseases such as avian influenza, brucellosis, and leptospirosis can be transmitted between animals and humans, emphasizing the need for robust diagnostic tools. Advances in diagnostic technologies, such as PCR (Polymerase Chain Reaction) and next-generation sequencing, have revolutionized the accuracy and speed of veterinary infectious disease diagnostics. These technologies allow for early detection and precise identification of pathogens. The growing trend of pet ownership has led to an increased demand for veterinary services, including diagnostics. Pet owners are increasingly investing in preventive healthcare for their animals, driving the demand for sophisticated diagnostic tests. With the globalization of the livestock industry, the risk of disease transmission across borders has escalated. This has prompted regulatory bodies and stakeholders to implement stringent diagnostic protocols to ensure the health and safety of animals and consumers.
Key Market Drivers
Increasing Pet Ownership and Humanization of Pets is Driving the Global Veterinary Infectious Disease Diagnostics Market.
In recent years, there has been a notable global shift in the way people perceive and care for their pets. The increasing trend of pet ownership and the growing humanization of pets have not only led to an upsurge in spending on pet healthcare but have also been significant drivers of the veterinary infectious disease diagnostics market. This market, which plays a crucial role in ensuring the health and well-being of animals, has witnessed unprecedented growth as pet owners seek advanced diagnostic solutions for their beloved companions. The worldwide surge in pet ownership is a multifaceted phenomenon, influenced by factors such as urbanization, changing lifestyles, and an increased understanding of the emotional and physical benefits that pets bring to their owners. As more people open their homes to pets, whether they be dogs, cats, birds, or exotic animals, the demand for comprehensive veterinary care has risen significantly.
This burgeoning population of pets has given rise to a corresponding demand for advanced diagnostic tools to detect and manage infectious diseases. Veterinary infectious disease diagnostics encompass a range of tests and procedures that aid in the identification and monitoring of diseases in animals. These diagnostics not only help in the early detection of illnesses but also play a crucial role in preventing the spread of infectious diseases among animals and, in some cases, to humans.
The increasing humanization of pets is another major trend shaping the veterinary infectious disease diagnostics market. Pet owners are now more inclined to view their animals as integral members of the family, leading to a greater willingness to invest in their health and well-being. This paradigm shift has translated into higher expectations for the quality of veterinary care, including advanced diagnostics, and has fueled the growth of the global market. Pet owners are seeking not just basic veterinary services but also cutting-edge diagnostics that can provide more accurate and timely results. This shift in consumer behaviour has prompted veterinary diagnostic companies to innovate and develop new technologies and testing methods to meet the evolving demands of pet owners.
Rising Incidence of Zoonotic Diseases is Driving the Global Veterinary Infectious Disease Diagnostics Market
Zoonotic diseases, which are infections that can be transmitted between animals and humans, have garnered increased attention in recent years due to their potential for rapid spread and devastating impact on both animal and human populations. The rise in these diseases has led to a growing demand for effective diagnostic tools, driving the expansion of the global veterinary infectious disease diagnostics market. Zoonotic diseases represent a significant public health concern, as evidenced by outbreaks such as the H1N1 influenza pandemic and the more recent COVID-19 pandemic. These diseases can originate in animals and jump to humans through various means, including direct contact, consumption of contaminated food or water, and exposure to vectors like mosquitoes and ticks.
The interconnectedness of animal and human health is increasingly recognized as a crucial aspect of global health. As human populations expand and encroach on natural habitats, the risk of zoonotic disease transmission escalates. Climate change, international travel, and the global movement of goods further contribute to the complexity of disease transmission dynamics. Efficient and accurate diagnostics play a pivotal role in preventing, controlling, and managing zoonotic diseases. In response to the rising threat, the global veterinary infectious disease diagnostics market has witnessed substantial growth. Diagnostic techniques include traditional methods such as serological testing and microbial culture, as well as advanced molecular techniques like polymerase chain reaction (PCR) and next-generation sequencing.
Key Market Challenges
High Cost of Diagnostic Equipment
The field of veterinary diagnostics plays a crucial role in safeguarding the health of animals and preventing the spread of infectious diseases. As technology continues to advance, the demand for accurate and timely diagnostics in the veterinary sector has grown exponentially. However, one formidable challenge hindering the progress of the Global Veterinary Infectious Disease Diagnostics Market is the exorbitant cost associated with diagnostic equipment. The high cost of diagnostic equipment limits access to advanced veterinary diagnostics, especially in developing regions. Rural areas, where agriculture is a significant part of the economy, often lack access to state-of-the-art diagnostic tools. This limited accessibility can impede early detection and timely intervention, allowing infectious diseases to spread unchecked.
Veterinary clinics and laboratories, facing the burden of expensive diagnostic equipment, may struggle to invest in the latest technologies. The financial strain on these establishments not only affects their ability to provide cutting-edge services but also impacts their competitiveness in the market. High equipment costs can also hinder research and development efforts in veterinary diagnostics. Smaller companies and research institutions may find it challenging to invest in innovative technologies, slowing down progress in the field and limiting the development of new diagnostic methods. The cost of diagnostic services is inevitably passed on to pet owners and livestock farmers. This can deter individuals from seeking early diagnostic testing for their animals, leading to delayed disease detection and increased treatment costs in the long run.
Key Market Trends
Technological Advancements
In recent years, the global veterinary industry has experienced a significant transformation, with a sharp focus on technological advancements to address the challenges posed by infectious diseases in animals. The Veterinary Infectious Disease Diagnostics Market has witnessed a remarkable surge, driven by cutting-edge technologies that are revolutionizing the way diseases are diagnosed and treated in animals. One of the primary drivers of the veterinary infectious disease diagnostics market is the continuous evolution of diagnostic technologies. Traditional methods are being replaced or complemented by more sophisticated and rapid techniques. Molecular diagnostics, next-generation sequencing, and advanced imaging technologies have become instrumental in providing quick and accurate diagnoses. These technologies not only enhance the speed of diagnosis but also improve the precision and reliability of results.
Segmental Insights
Technology Insights
Based on the category of technology, Immunodiagnostics emerged as the dominant player in the global market for Veterinary Infectious Disease Diagnostics in 2022. Immunodiagnostics relies on the highly specific interactions between antibodies and antigens. This specificity allows for accurate detection of pathogens, minimizing the chances of false-positive or false-negative results. High sensitivity ensures that even low levels of infection can be identified, enabling early intervention and treatment. One of the significant advantages of immunodiagnostics is its ability to deliver rapid results. Quick and accurate diagnosis is crucial in preventing the spread of infectious diseases within animal populations and reducing the economic impact on the agricultural and veterinary sectors.
Animal Type Insights
The Companion Animals segment is projected to experience rapid growth during the forecast period. Companion animals, which include pets like dogs, cats, and horses, have become integral members of households worldwide. The deep emotional bonds shared between humans and their furry friends have elevated the status of these animals from mere pets to cherished family members. As the number of companion animals continues to rise globally, so does the concern for their health and well-being. The Companion Animals segment's dominance in the veterinary infectious disease diagnostics market can be attributed to several key factors. The increasing pet ownership rates, rising awareness about animal health, and a growing trend of preventive healthcare for pets are some of the primary drivers. Moreover, the evolving regulatory landscape and a surge in research and development activities in the veterinary diagnostics sector have further propelled market growth. The demand for accurate and efficient diagnostic tools for companion animals has prompted companies to invest in innovative solutions, fostering a competitive yet dynamic market.
Regional Insights
North America emerged as the dominant player in the global Veterinary Infectious Disease Diagnostics market in 2022, holding the largest market share in terms of value. North America, particularly the United States and Canada, has been at the forefront of technological innovation in the healthcare and diagnostics industries. The region's commitment to research and development has resulted in cutting-edge diagnostic tools and techniques, enabling more accurate and timely identification of infectious diseases in animals. The rising trend of pet ownership in North America has led to a surge in demand for advanced veterinary diagnostics. Pet owners are increasingly investing in the health and well-being of their animals, driving the need for sophisticated diagnostic tools to identify and manage infectious diseases effectively.
Key Market Players
BIOMЙRIEUX
Heska Corporation
Neogen Corporation
INDICAL BIOSCIENCE GmbH
Randox Laboratories Ltd.
Thermo Fisher Scientific Inc.
Creative Diagnostics
DRG INSTRUMENTS GMBH
Chembio Diagnostic Systems, Inc.
Eurofins Technologies
Agrolabo S.p.A.
Abbott Laboratories inc.
Danaher Corporation
Report Scope:
In this report, the Global Veterinary Infectious Disease Diagnostics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
- Veterinary Infectious Disease Diagnostics Market, By Product:
- Immunodiagnostics
- Molecular Diagnostics
- Other Veterinary Diagnostic Technologies
- Veterinary Infectious Disease Diagnostics Market, By Animal Type :
- Companion Animals
- Food Producing Animals
- Veterinary Infectious Disease Diagnostics Market, By End user:
- Reference Laboratories
- Veterinary Laboratories and Clinics
- Point of Care / In House Testing
- Research Institutes and Universities
- Veterinary Infectious Disease Diagnostics Market, By Region:
- North America
- United States
- Canada
- Mexico
- Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
- Asia-Pacific
- China
- India
- Japan
- Australia
- South Korea
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Company Profiles: Detailed analysis of the major companies present in the Veterinary Infectious Disease Diagnostics Market.
Available Customizations:
Global Veterinary Infectious Disease Diagnostics market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
1. PRODUCT OVERVIEW
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. RESEARCH METHODOLOGY
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validations
2.7. Assumptions and Limitations
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. VOICE OF CUSTOMER
5. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Technology (Immunodiagnostics, Molecular Diagnostics, Other Veterinary Diagnostic Technologies)
5.2.2. By Animal Type (Companion Animals, Food Producing Animals)
5.2.3. By End User (Reference Laboratories, Veterinary Laboratories and Clinics, Point of Care / In House Testing, Research Institutes and Universities)
5.2.4. By Region
5.2.5. By Company (2022)
5.3. Market Map
5.3.1. By Technology
5.3.2. By Animal Type
5.3.3. By End User
5.3.4. By Region
6. NORTH AMERICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Technology
6.2.2. By Animal Type
6.2.3. By End User
6.2.4. By Country
6.2.4.1. United States Veterinary Infectious Disease Diagnostics Market Outlook
6.2.4.1.1. Market Size & Forecast
6.2.4.1.1.1. By Value
6.2.4.1.2. Market Share & Forecast
6.2.4.1.2.1. By Technology
6.2.4.1.2.2. By Animal Type
6.2.4.1.2.3. By End User
6.2.4.2. Canada Veterinary Infectious Disease Diagnostics Market Outlook
6.2.4.2.1. Market Size & Forecast
6.2.4.2.1.1. By Value
6.2.4.2.2. Market Share & Forecast
6.2.4.2.2.1. By Technology
6.2.4.2.2.2. By Animal Type
6.2.4.2.2.3. By End User
6.2.4.3. Mexico Veterinary Infectious Disease Diagnostics Market Outlook
6.2.4.3.1. Market Size & Forecast
6.2.4.3.1.1. By Value
6.2.4.3.2. Market Share & Forecast
6.2.4.3.2.1. By Technology
6.2.4.3.2.2. By Animal Type
6.2.4.3.2.3. By End User
7. EUROPE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Technology
7.2.2. By Animal Type
7.2.3. By End User
7.2.4. By Country
7.2.4.1. France Veterinary Infectious Disease Diagnostics Market Outlook
7.2.4.1.1. Market Size & Forecast
7.2.4.1.1.1. By Value
7.2.4.1.2. Market Share & Forecast
7.2.4.1.2.1. By Technology
7.2.4.1.2.2. By Animal Type
7.2.4.1.2.3. By End User
7.2.4.2. Germany Veterinary Infectious Disease Diagnostics Market Outlook
7.2.4.2.1. Market Size & Forecast
7.2.4.2.1.1. By Value
7.2.4.2.2. Market Share & Forecast
7.2.4.2.2.1. By Technology
7.2.4.2.2.2. By Animal Type
7.2.4.2.2.3. By End User
7.2.4.3. United Kingdom Veterinary Infectious Disease Diagnostics Market Outlook
7.2.4.3.1. Market Size & Forecast
7.2.4.3.1.1. By Value
7.2.4.3.2. Market Share & Forecast
7.2.4.3.2.1. By Technology
7.2.4.3.2.2. By Animal Type
7.2.4.3.2.3. By End User
7.2.4.4. Italy Veterinary Infectious Disease Diagnostics Market Outlook
7.2.4.4.1. Market Size & Forecast
7.2.4.4.1.1. By Value
7.2.4.4.2. Market Share & Forecast
7.2.4.4.2.1. By Technology
7.2.4.4.2.2. By Animal Type
7.2.4.4.2.3. By End User
7.2.4.5. Spain Veterinary Infectious Disease Diagnostics Market Outlook
7.2.4.5.1. Market Size & Forecast
7.2.4.5.1.1. By Value
7.2.4.5.2. Market Share & Forecast
7.2.4.5.2.1. By Technology
7.2.4.5.2.2. By Animal Type
7.2.4.5.2.3. By End User
8. ASIA PACIFIC VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Technology
8.2.2. By Animal Type
8.2.3. By End User
8.2.4. By Country
8.2.4.1. China Veterinary Infectious Disease Diagnostics Market Outlook
8.2.4.1.1. Market Size & Forecast
8.2.4.1.1.1. By Value
8.2.4.1.2. Market Share & Forecast
8.2.4.1.2.1. By Technology
8.2.4.1.2.2. By Animal Type
8.2.4.1.2.3. By End User
8.2.4.2. India Veterinary Infectious Disease Diagnostics Market Outlook
8.2.4.2.1. Market Size & Forecast
8.2.4.2.1.1. By Value
8.2.4.2.2. Market Share & Forecast
8.2.4.2.2.1. By Technology
8.2.4.2.2.2. By Animal Type
8.2.4.2.2.3. By End User
8.2.4.3. South Korea Veterinary Infectious Disease Diagnostics Market Outlook
8.2.4.3.1. Market Size & Forecast
8.2.4.3.1.1. By Value
8.2.4.3.2. Market Share & Forecast
8.2.4.3.2.1. By Technology
8.2.4.3.2.2. By Animal Type
8.2.4.3.2.3. By End User
8.2.4.4. Japan Veterinary Infectious Disease Diagnostics Market Outlook
8.2.4.4.1. Market Size & Forecast
8.2.4.4.1.1. By Value
8.2.4.4.2. Market Share & Forecast
8.2.4.4.2.1. By Technology
8.2.4.4.2.2. By Animal Type
8.2.4.4.2.3. By End User
8.2.4.5. Australia Veterinary Infectious Disease Diagnostics Market Outlook
8.2.4.5.1. Market Size & Forecast
8.2.4.5.1.1. By Value
8.2.4.5.2. Market Share & Forecast
8.2.4.5.2.1. By Technology
8.2.4.5.2.2. By Animal Type
8.2.4.5.2.3. By End User
9. SOUTH AMERICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Technology
9.2.2. By Animal Type
9.2.3. By End User
9.2.4. By Country
9.2.4.1. Brazil Veterinary Infectious Disease Diagnostics Market Outlook
9.2.4.1.1. Market Size & Forecast
9.2.4.1.1.1. By Value
9.2.4.1.2. Market Share & Forecast
9.2.4.1.2.1. By Technology
9.2.4.1.2.2. By Animal Type
9.2.4.1.2.3. By End User
9.2.4.2. Argentina Veterinary Infectious Disease Diagnostics Market Outlook
9.2.4.2.1. Market Size & Forecast
9.2.4.2.1.1. By Value
9.2.4.2.2. Market Share & Forecast
9.2.4.2.2.1. By Technology
9.2.4.2.2.2. By Animal Type
9.2.4.2.2.3. By End User
9.2.4.3. Colombia Veterinary Infectious Disease Diagnostics Market Outlook
9.2.4.3.1. Market Size & Forecast
9.2.4.3.1.1. By Value
9.2.4.3.2. Market Share & Forecast
9.2.4.3.2.1. By Technology
9.2.4.3.2.2. By Animal Type
9.2.4.3.2.3. By End User
10. MIDDLE EAST & AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Technology
10.2.2. By Animal Type
10.2.3. By End User
10.2.4. By Country
10.2.4.1. South Africa Veterinary Infectious Disease Diagnostics Market Outlook
10.2.4.1.1. Market Size & Forecast
10.2.4.1.1.1. By Value
10.2.4.1.2. Market Share & Forecast
10.2.4.1.2.1. By Technology
10.2.4.1.2.2. By Animal Type
10.2.4.1.2.3. By End User
10.2.4.2. Saudi Arabia Veterinary Infectious Disease Diagnostics Market Outlook
10.2.4.2.1. Market Size & Forecast
10.2.4.2.1.1. By Value
10.2.4.2.2. Market Share & Forecast
10.2.4.2.2.1. By Technology
10.2.4.2.2.2. By Animal Type
10.2.4.2.2.3. By End User
10.2.4.3. UAE Veterinary Infectious Disease Diagnostics Market Outlook
10.2.4.3.1. Market Size & Forecast
10.2.4.3.1.1. By Value
10.2.4.3.2. Market Share & Forecast
10.2.4.3.2.1. By Technology
10.2.4.3.2.2. By Animal Type
10.2.4.3.2.3. By End User
11. MARKET DYNAMICS
11.1. Drivers
11.2. Challenges
12. MARKET TRENDS & DEVELOPMENTS
12.1. Recent Development
12.2. Mergers & Acquisitions
12.3. Product Launches
13. COMPETITIVE LANDSCAPE
13.1. BIOMЙRIEUX
13.1.1. Business Overview
13.1.2. Patient Offerings
13.1.3. Recent Developments
13.1.4. Key Personnel
13.1.5. SWOT Analysis
13.2. Origin Instruments Corporation
13.3. Heska Corporation
13.4. Neogen Corporation
13.5. INDICAL BIOSCIENCE GmbH
13.6. Randox Laboratories Ltd.
13.7. Thermo Fisher Scientific Inc.
13.8. Creative Diagnostics
13.9. DRG INSTRUMENTS GMBH
13.10. Chembio Diagnostic Systems, Inc.
13.11. Eurofins Technologies
13.12. Agrolabo S.p.A.
13.13. Abbott Laboratories inc.
13.14. Danaher Corporation
14. STRATEGIC RECOMMENDATIONS
15. ABOUT US & DISCLAIMER
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. RESEARCH METHODOLOGY
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validations
2.7. Assumptions and Limitations
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. VOICE OF CUSTOMER
5. GLOBAL VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Technology (Immunodiagnostics, Molecular Diagnostics, Other Veterinary Diagnostic Technologies)
5.2.2. By Animal Type (Companion Animals, Food Producing Animals)
5.2.3. By End User (Reference Laboratories, Veterinary Laboratories and Clinics, Point of Care / In House Testing, Research Institutes and Universities)
5.2.4. By Region
5.2.5. By Company (2022)
5.3. Market Map
5.3.1. By Technology
5.3.2. By Animal Type
5.3.3. By End User
5.3.4. By Region
6. NORTH AMERICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Technology
6.2.2. By Animal Type
6.2.3. By End User
6.2.4. By Country
6.2.4.1. United States Veterinary Infectious Disease Diagnostics Market Outlook
6.2.4.1.1. Market Size & Forecast
6.2.4.1.1.1. By Value
6.2.4.1.2. Market Share & Forecast
6.2.4.1.2.1. By Technology
6.2.4.1.2.2. By Animal Type
6.2.4.1.2.3. By End User
6.2.4.2. Canada Veterinary Infectious Disease Diagnostics Market Outlook
6.2.4.2.1. Market Size & Forecast
6.2.4.2.1.1. By Value
6.2.4.2.2. Market Share & Forecast
6.2.4.2.2.1. By Technology
6.2.4.2.2.2. By Animal Type
6.2.4.2.2.3. By End User
6.2.4.3. Mexico Veterinary Infectious Disease Diagnostics Market Outlook
6.2.4.3.1. Market Size & Forecast
6.2.4.3.1.1. By Value
6.2.4.3.2. Market Share & Forecast
6.2.4.3.2.1. By Technology
6.2.4.3.2.2. By Animal Type
6.2.4.3.2.3. By End User
7. EUROPE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Technology
7.2.2. By Animal Type
7.2.3. By End User
7.2.4. By Country
7.2.4.1. France Veterinary Infectious Disease Diagnostics Market Outlook
7.2.4.1.1. Market Size & Forecast
7.2.4.1.1.1. By Value
7.2.4.1.2. Market Share & Forecast
7.2.4.1.2.1. By Technology
7.2.4.1.2.2. By Animal Type
7.2.4.1.2.3. By End User
7.2.4.2. Germany Veterinary Infectious Disease Diagnostics Market Outlook
7.2.4.2.1. Market Size & Forecast
7.2.4.2.1.1. By Value
7.2.4.2.2. Market Share & Forecast
7.2.4.2.2.1. By Technology
7.2.4.2.2.2. By Animal Type
7.2.4.2.2.3. By End User
7.2.4.3. United Kingdom Veterinary Infectious Disease Diagnostics Market Outlook
7.2.4.3.1. Market Size & Forecast
7.2.4.3.1.1. By Value
7.2.4.3.2. Market Share & Forecast
7.2.4.3.2.1. By Technology
7.2.4.3.2.2. By Animal Type
7.2.4.3.2.3. By End User
7.2.4.4. Italy Veterinary Infectious Disease Diagnostics Market Outlook
7.2.4.4.1. Market Size & Forecast
7.2.4.4.1.1. By Value
7.2.4.4.2. Market Share & Forecast
7.2.4.4.2.1. By Technology
7.2.4.4.2.2. By Animal Type
7.2.4.4.2.3. By End User
7.2.4.5. Spain Veterinary Infectious Disease Diagnostics Market Outlook
7.2.4.5.1. Market Size & Forecast
7.2.4.5.1.1. By Value
7.2.4.5.2. Market Share & Forecast
7.2.4.5.2.1. By Technology
7.2.4.5.2.2. By Animal Type
7.2.4.5.2.3. By End User
8. ASIA PACIFIC VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Technology
8.2.2. By Animal Type
8.2.3. By End User
8.2.4. By Country
8.2.4.1. China Veterinary Infectious Disease Diagnostics Market Outlook
8.2.4.1.1. Market Size & Forecast
8.2.4.1.1.1. By Value
8.2.4.1.2. Market Share & Forecast
8.2.4.1.2.1. By Technology
8.2.4.1.2.2. By Animal Type
8.2.4.1.2.3. By End User
8.2.4.2. India Veterinary Infectious Disease Diagnostics Market Outlook
8.2.4.2.1. Market Size & Forecast
8.2.4.2.1.1. By Value
8.2.4.2.2. Market Share & Forecast
8.2.4.2.2.1. By Technology
8.2.4.2.2.2. By Animal Type
8.2.4.2.2.3. By End User
8.2.4.3. South Korea Veterinary Infectious Disease Diagnostics Market Outlook
8.2.4.3.1. Market Size & Forecast
8.2.4.3.1.1. By Value
8.2.4.3.2. Market Share & Forecast
8.2.4.3.2.1. By Technology
8.2.4.3.2.2. By Animal Type
8.2.4.3.2.3. By End User
8.2.4.4. Japan Veterinary Infectious Disease Diagnostics Market Outlook
8.2.4.4.1. Market Size & Forecast
8.2.4.4.1.1. By Value
8.2.4.4.2. Market Share & Forecast
8.2.4.4.2.1. By Technology
8.2.4.4.2.2. By Animal Type
8.2.4.4.2.3. By End User
8.2.4.5. Australia Veterinary Infectious Disease Diagnostics Market Outlook
8.2.4.5.1. Market Size & Forecast
8.2.4.5.1.1. By Value
8.2.4.5.2. Market Share & Forecast
8.2.4.5.2.1. By Technology
8.2.4.5.2.2. By Animal Type
8.2.4.5.2.3. By End User
9. SOUTH AMERICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Technology
9.2.2. By Animal Type
9.2.3. By End User
9.2.4. By Country
9.2.4.1. Brazil Veterinary Infectious Disease Diagnostics Market Outlook
9.2.4.1.1. Market Size & Forecast
9.2.4.1.1.1. By Value
9.2.4.1.2. Market Share & Forecast
9.2.4.1.2.1. By Technology
9.2.4.1.2.2. By Animal Type
9.2.4.1.2.3. By End User
9.2.4.2. Argentina Veterinary Infectious Disease Diagnostics Market Outlook
9.2.4.2.1. Market Size & Forecast
9.2.4.2.1.1. By Value
9.2.4.2.2. Market Share & Forecast
9.2.4.2.2.1. By Technology
9.2.4.2.2.2. By Animal Type
9.2.4.2.2.3. By End User
9.2.4.3. Colombia Veterinary Infectious Disease Diagnostics Market Outlook
9.2.4.3.1. Market Size & Forecast
9.2.4.3.1.1. By Value
9.2.4.3.2. Market Share & Forecast
9.2.4.3.2.1. By Technology
9.2.4.3.2.2. By Animal Type
9.2.4.3.2.3. By End User
10. MIDDLE EAST & AFRICA VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Technology
10.2.2. By Animal Type
10.2.3. By End User
10.2.4. By Country
10.2.4.1. South Africa Veterinary Infectious Disease Diagnostics Market Outlook
10.2.4.1.1. Market Size & Forecast
10.2.4.1.1.1. By Value
10.2.4.1.2. Market Share & Forecast
10.2.4.1.2.1. By Technology
10.2.4.1.2.2. By Animal Type
10.2.4.1.2.3. By End User
10.2.4.2. Saudi Arabia Veterinary Infectious Disease Diagnostics Market Outlook
10.2.4.2.1. Market Size & Forecast
10.2.4.2.1.1. By Value
10.2.4.2.2. Market Share & Forecast
10.2.4.2.2.1. By Technology
10.2.4.2.2.2. By Animal Type
10.2.4.2.2.3. By End User
10.2.4.3. UAE Veterinary Infectious Disease Diagnostics Market Outlook
10.2.4.3.1. Market Size & Forecast
10.2.4.3.1.1. By Value
10.2.4.3.2. Market Share & Forecast
10.2.4.3.2.1. By Technology
10.2.4.3.2.2. By Animal Type
10.2.4.3.2.3. By End User
11. MARKET DYNAMICS
11.1. Drivers
11.2. Challenges
12. MARKET TRENDS & DEVELOPMENTS
12.1. Recent Development
12.2. Mergers & Acquisitions
12.3. Product Launches
13. COMPETITIVE LANDSCAPE
13.1. BIOMЙRIEUX
13.1.1. Business Overview
13.1.2. Patient Offerings
13.1.3. Recent Developments
13.1.4. Key Personnel
13.1.5. SWOT Analysis
13.2. Origin Instruments Corporation
13.3. Heska Corporation
13.4. Neogen Corporation
13.5. INDICAL BIOSCIENCE GmbH
13.6. Randox Laboratories Ltd.
13.7. Thermo Fisher Scientific Inc.
13.8. Creative Diagnostics
13.9. DRG INSTRUMENTS GMBH
13.10. Chembio Diagnostic Systems, Inc.
13.11. Eurofins Technologies
13.12. Agrolabo S.p.A.
13.13. Abbott Laboratories inc.
13.14. Danaher Corporation
14. STRATEGIC RECOMMENDATIONS
15. ABOUT US & DISCLAIMER
